A phase II double-blind randomized study of the simultaneous administration of recombinant human interleukin-6 and recombinant human granulocyte colony-stimulating factor following paclitaxel and carboplatin chemotherapy in patients with advanced epithelial ovarian cancer
Article
Hochster, H, Speyer, JL, Mandeli, JP et al. (1999). A phase II double-blind randomized study of the simultaneous administration of recombinant human interleukin-6 and recombinant human granulocyte colony-stimulating factor following paclitaxel and carboplatin chemotherapy in patients with advanced epithelial ovarian cancer
. GYNECOLOGIC ONCOLOGY, 72(3), 292-297. 10.1006/gyno.1998.5261
Hochster, H, Speyer, JL, Mandeli, JP et al. (1999). A phase II double-blind randomized study of the simultaneous administration of recombinant human interleukin-6 and recombinant human granulocyte colony-stimulating factor following paclitaxel and carboplatin chemotherapy in patients with advanced epithelial ovarian cancer
. GYNECOLOGIC ONCOLOGY, 72(3), 292-297. 10.1006/gyno.1998.5261